Prostate Screening Tests Used Even if They Don’t Provide Value
Shifting guidelines for prostate cancer screening lead to uncertainty on when and if prostate screening tests should be ordered.
Shifting guidelines for prostate cancer screening lead to uncertainty on when and if prostate screening tests should be ordered.
A new study investigated genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
The incidence rate of metastatic prostate cancer increased for men 45 and older and coincides with recommendations against screenings.
In a large study, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions by the USPSTF on screening.
Read MoreBlack, Hispanic, and Asian men were less likely to receive a popular prostate cancer test that can eliminate the need for an invasive biopsy.
Read MoreA prostate cancer urine test can identify men at intermediate risk who can safely avoid immediate treatment and benefit from active surveillance instead.
Read MoreResearchers believe that men with Lynch syndrome could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer.
Read MoreRoche has entered an agreement with Ibex Medical Analytics, a provider of artificial intelligence (AI)-based cancer diagnostics.
Read MoreNew research from a team of scientists — and two specially trained dogs — have scientifically validated man’s best friend can “sniff out” prostate cancer.
Read MoreResearchers have developed noninvasive tests that use either blood or saliva samples to diagnose colorectal cancer or prostate cancer, respectively.
Read MoreThe U.S. Food and Drug Administration (FDA) has authorized marketing of software to assist medical pathologists in detecting areas suspicious for cancer.
Read MoreDuring the pandemic, studies have shown many men are missing or delaying routine health screenings, including prostate cancer screenings.
Read MoreResearchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging...
Read MoreBecause of the covid-19 pandemic, nearly 10 million patients weren’t screened for cancer, including breast, colorectal, and prostate.
Read MoreMedical Diagnostic Laboratories’ approach blends DNA-based molecular testing with traditional pathology and cytology tests to aid in diagnosing or screening for urologic conditions.
Read MoreProscia and Ibex Medical Analytics are collaborating to deliver a unified software solution that powers AI-enabled workflows for prostate cancer diagnosis.
Read MoreNew research demonstrates the ability of dogs to detect aggressive prostate cancer from urine samples and suggests that an artificial neural network could learn from this olfactory ability, with an eye toward replicating it in novel detection tools.
Read MoreUnder this new partnership, Propella and NCI will conduct a multi-center clinical trial to evaluate abiraterone decanoate as a new therapy for metastatic prostate cancer.
Read More